Bleichroeder Acquisition CORP I Form 4 insider transactions

Insider transactions: buys and sells by directors, officers and ten percent owners, filed within two business days of the trade.

NASDAQ
Merlin, Inc. CFO Ryan Carrithers was granted 256,416 restricted stock units and 806,393 stock options as part of a compensation package.
NASDAQ
Director Kenneth John Braithwaite was granted 37,500 restricted stock units in Merlin, Inc. as part of an equity award.
NASDAQ
Director Robert Smith acquired 37,500 restricted stock units in Merlin, Inc. as part of an equity compensation award.
NASDAQ
Director Kelyn Brannon was granted 37,500 restricted stock units in Merlin, Inc. as part of an equity compensation award.
NASDAQ
Director Michael Blitzer was granted 37,500 restricted stock units in Merlin, Inc. as part of an equity compensation award.
NASDAQ
Director Michael Montelongo was granted 37,500 restricted stock units in Merlin, Inc. as part of a compensation award.
NASDAQ
Chief Revenue Officer Mark Rawlins Brunner was granted 225,904 restricted stock units in Merlin, Inc.
NASDAQ
Director Carolyn Trabuco was granted 37,500 restricted stock units in Merlin, Inc. as part of an equity compensation award.
NASDAQ
Merlin Inc. CLO and Secretary Leslie Renee Ravestein was granted 199,036 restricted stock units and 205,475 stock options.
NASDAQ
Merlin, Inc. CEO George Matthew Spencer was granted 531,807 restricted stock units as part of an equity compensation award.
NASDAQ
Merlin Labs successfully completed the Preliminary Design Review for its C-130J autonomy program with USSOCOM, advancing its $105 million contract.
NASDAQ
Goldman Sachs Group Inc. and Goldman Sachs & Co. LLC reported a series of market-making transactions in Inflection Point Acquisition Corp. IV's Class A Common Stock, ceasing to be a greater than 10% beneficial owner as of February 5, 2026.
NASDAQ
Merlin Labs, an autonomous flight technology company, will host an investor and analyst webinar on March 3, 2026, to discuss its pending business combination with Inflection Point Acquisition Corp. IV.
NASDAQ
Merlin Labs, an autonomous flight technology developer, is set to go public through a $1 billion SPAC merger with Inflection Point Acquisition Corp. IV.
NASDAQ
Merlin Labs expands its executive team with key hires in legal, people, and engineering roles, preparing for its upcoming public listing via a business combination with Inflection Point Acquisition Corp. IV.
NASDAQ
Merlin increased its committed PIPE to $200M for its planned merger with Inflection Point Acquisition Corp. IV, bolstering cash for expansion and M&A ahead of an expected early-2026 listing.
NASDAQ
Merlin Labs and Inflection Point Acquisition Corp. IV announced a significant increase in their PIPE investment to over $200 million, strengthening Merlin's balance sheet ahead of their proposed business combination.
NASDAQ
Merlin Labs, preparing for a public listing via a business combination with Inflection Point Acquisition Corp. IV, has appointed Ryan Carrithers as its new Chief Financial Officer.
NASDAQ
Merlin Labs successfully reached its second Stage of Involvement milestone with the Civil Aviation Authority of New Zealand, advancing its autonomous flight technology toward certification.
NASDAQ
Merlin Labs, set to go public via SPAC, announced a Cooperative Research and Development Agreement with the U.S. Air Force to advance autonomous contingency management capabilities.
NASDAQ
Merlin Labs announced a strategic partnership with GE Aerospace to develop next-generation autonomy and pilot-assist platforms for military and civil aircraft, enhancing crew reduction and uncrewed flight capabilities.
NASDAQ
Merlin Labs, a developer of AI-enabled autonomous flight technology, will go public through a business combination with Bleichroeder Acquisition Corp. I, valuing Merlin at $800 million pre-money.
NASDAQ
Bleichroeder Sponsor 1 LLC, along with directors and officers, report acquisition of Class A ordinary shares and cancellation of Class B ordinary shares following the IPO of Bleichroeder Acquisition Corp. I.